The Asia Pacific region is expected to exhibit the fastest growth in the Semaglutide market with a share of 25.2% in 2026, driven by rising awareness about metabolic diseases and increasing healthcare expenditure
While working with Habener's group Mojsov came into contact with Daniel Drucker (figure 25), a Canadian who came to get some laboratory training with Habener in the summer of 1984
Specific to bariatric surgery, the clinical experts noted that in addition to barriers to access, not all patients are interested in pursuing this option because of the potential risks associated with surgery
Rather than offering medical advice, the book provides a structured behavioural approach grounded in cognitive and health psychology
Semaglutide is a GLP-1 receptor agonist, which means it mimics the action of the glucagon-like peptide-1 hormone that regulates appetite and food intake
Its science-backed, lifestyle-focused, and designed just for you